Fidan, E. Et Al. 2011. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. ACTA DIABETOLOGICA , vol.48, no.4 , 297-302.

Fidan, E., Ersoz, H. O., Yilmaz, M., Yılmaz, H., KOÇAK, M., Karahan, C., ... Erem, C.(2011). The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. ACTA DIABETOLOGICA , vol.48, no.4, 297-302.

Fidan, EVREN Et Al. "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus," ACTA DIABETOLOGICA , vol.48, no.4, 297-302, 2011

Fidan, EVREN Et Al. "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus." ACTA DIABETOLOGICA , vol.48, no.4, pp.297-302, 2011

Fidan, E. Et Al. (2011) . "The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus." ACTA DIABETOLOGICA , vol.48, no.4, pp.297-302.

@article{article, author={EVREN FİDAN Et Al. }, title={The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus}, journal={ACTA DIABETOLOGICA}, year=2011, pages={297-302} }